T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Exxon Mobil
XOM
|
+$1.68B |
| 2 |
Eli Lilly
LLY
|
+$1.43B |
| 3 |
Bank of America
BAC
|
+$1.17B |
| 4 |
Tesla
TSLA
|
+$1.13B |
| 5 |
Wells Fargo
WFC
|
+$734M |
Top Sells
| 1 |
TMX
Terminix Global Holdings, Inc.
TMX
|
+$20.6B |
| 2 |
Microsoft
MSFT
|
+$5.74B |
| 3 |
Amazon
AMZN
|
+$3.33B |
| 4 |
Yum! Brands
YUM
|
+$2.6B |
| 5 |
Salesforce
CRM
|
+$2.35B |
Sector Composition
| 1 | Technology | 26.11% |
| 2 | Healthcare | 18.73% |
| 3 | Consumer Discretionary | 14.62% |
| 4 | Financials | 10.33% |
| 5 | Communication Services | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2601
Xeris Biopharma Holdings
XERS
$1.26B
| $162K | ﹤0.01% |
103,609
+66,975
| +183% | +$105K |
|
2602
Mirion Technologies
MIR
$4.92B
| $161K | ﹤0.01% |
21,492
+8,422
| +64% | +$63.1K |
|
2603
Purple Innovation
PRPL
$116M
| $161K | ﹤0.01% |
39,732
+24,577
| +162% | +$99.6K |
|
2604
Quantum Corp
QMCO
$114M
| $159K | ﹤0.01% |
7,320
+1,020
| +16% | +$22.2K |
|
2605
Atea Pharmaceuticals
AVIR
$250M
| $158K | ﹤0.01% |
27,621
+4,540
| +20% | +$26K |
|
2606
American Axle
AXL
$704M
| $158K | ﹤0.01% |
23,121
+7,510
| +48% | +$51.3K |
|
2607
Perimeter Solutions
PRM
$3.22B
| $158K | ﹤0.01% |
19,709
+8,085
| +70% | +$64.8K |
|
2608
Telos
TLS
$469M
| $156K | ﹤0.01% |
17,530
-5,510
| -24% | -$49K |
|
2609
Wave Life Sciences
WVE
$1.18B
| $156K | ﹤0.01% |
43,080
+14,100
| +49% | +$51.1K |
|
2610
Energy Fuels
UUUU
$2.91B
| $155K | ﹤0.01% |
25,258
+10,141
| +67% | +$62.2K |
|
2611
Corsair Gaming
CRSR
$929M
| $154K | ﹤0.01% |
13,542
+2,285
| +20% | +$26K |
|
|
GAN
2612
DELISTED
GAN Ltd
GAN
| $153K | ﹤0.01% |
68,600
+33,200
| +94% | +$74K |
|
2613
Alaunos Therapeutics
TCRT
$4.83M
| $153K | ﹤0.01% |
590
-73
| -11% | -$18.9K |
|
2614
The ONE Group
STKS
$82.3M
| $152K | ﹤0.01% |
22,767
+8,808
| +63% | +$58.8K |
|
|
CNSL
2615
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
| $152K | ﹤0.01% |
36,403
-17,720
| -33% | -$74K |
|
2616
Cogent Biosciences
COGT
$1.78B
| $151K | ﹤0.01% |
+10,104
| New | +$151K |
|
|
USX
2617
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
| $151K | ﹤0.01% |
61,000
-2,739,381
| -98% | -$6.78M |
|
2618
Citizens
CIA
$273M
| $149K | ﹤0.01% |
44,500
+5,800
| +15% | +$19.4K |
|
2619
Golub Capital BDC
GBDC
$3.92B
| $149K | ﹤0.01% |
12,000
| – | – |
|
2620
McEwen Inc.
MUX
$742M
| $148K | ﹤0.01% |
45,380
+11,100
| +32% | +$36.2K |
|
|
DBD
2621
DELISTED
Diebold Nixdorf Incorporated
DBD
| $147K | ﹤0.01% |
59,893
+5,552
| +10% | +$13.6K |
|
2622
Beam Global
BEEM
$43.3M
| $146K | ﹤0.01% |
11,900
| – | – |
|
2623
4D Molecular Therapeutics
FDMT
$324M
| $146K | ﹤0.01% |
18,108
+2,318
| +15% | +$18.7K |
|
|
GOGL
2624
DELISTED
Golden Ocean Group
GOGL
| $144K | ﹤0.01% |
19,269
+7,554
| +64% | +$56.5K |
|
2625
Sotera Health
SHC
$4.47B
| $144K | ﹤0.01% |
20,984
+8,028
| +62% | +$55.1K |
|